You are here

McLean in the News

McLean In the News

29 Apr '16

Should the FDA Reclassify Marijuana? (Washington Post)

“Moving marijuana to Schedule II ‘to promote research’ is conceivably unethical, as marijuana would then be designated a safe and effective medicine in the absence of high-quality evidence.” – Dr. Bertha Madras

Pages